ad 5075 has been researched along with pioglitazone hydrochloride in 1 studies
| Studies (ad 5075) | Trials (ad 5075) | Recent Studies (post-2010) (ad 5075) | Studies (pioglitazone hydrochloride) | Trials (pioglitazone hydrochloride) | Recent Studies (post-2010) (pioglitazone hydrochloride) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 22 | 0 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Ikeda, H; Meguro, K; Mizuno, K; Momose, Y; Sohda, T | 1 |
1 other study(ies) available for ad 5075 and pioglitazone hydrochloride
| Article | Year |
|---|---|
Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
Topics: Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Mice; Pioglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones | 1992 |